Microbiology & Infectious Diseases

Daily prophylaxis with interferon-alpha (IFN-α) nasal spray significantly reduced the risk of COVID-19 infection in adult patients with cancer, according to findings from a randomized, double-blinded, placebo-controlled trial.

New evidence suggests that individuals with poorer pre-infection mental health and a higher burden of prior symptoms face a greater risk of developing long COVID, according to findings from a large national cohort study.

Methicillin-resistant Staphylococcus aureus (MRSA) infections are on the rise, with new statistical modeling showing significant links between community-acquired and hospital-acquired cases, age, and the COVID-19 pandemic.

Cervicovaginal secretions from young females with bacterial vaginosis (BV) were shown to enhance HIV infection in new research that underscores the biological mechanisms linking BV to increased HIV risk.

Pandemic-era disruptions have permanently altered the climate-influenza relationship, with new subtype-specific thresholds emerging in Southern China, according to a large-scale analysis spanning 2011 to 2024.

Severe Clostridioides difficile infection (CDI) can progress rapidly to organ failure and sepsis, and while most patients respond to antibiotic therapy, a minority face life-threatening disease that may require surgical intervention.

Candida kefyr, a yeast species historically considered a rare human pathogen, is now being identified as an emerging cause of invasive fungal infections in solid organ transplant recipients, according to a recent case report and literature review.

Nearly 8000 chikungunya cases have been reported in southern China since mid-June, according to national health officials, marking one of the country’s largest recorded outbreaks of the mosquito-borne virus.